KIF2C Antibodies

Santa Cruz Biotechnology delivers a wide array of KIF2C monoclonal antibodies for investigating KIF2C protein functions. KIF2C monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KIF2C, also known as kinesin family member 2C, is a motor protein that plays a critical role in mitosis by regulating microtubule dynamics and chromosome segregation. Proper KIF2C function is essential for maintaining genomic stability, and KIF2C dysregulation has been implicated in various cancers. Research into KIF2C mechanisms continues to reveal potential therapeutic targets for cancer treatment. Scientists worldwide use KIF2C monoclonal antibodies to explore cellular processes during mitosis and chromosome segregation. KIF2C research has expanded our understanding of cell division and its relationship to cancer development. Understanding KIF2C's role in genomic stability opens new avenues for therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies for KIF2C support researchers in advancing scientific knowledge and developing innovative cancer treatments.